Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Akira Shirasawa"'
Autor:
Akira Shirasawa, Hiroko Kajita, Kaori Iwabuchi, Yutaka Sasaki, Masaki Takahashi, Shun Ichi Maisawa, Yoko Matsuzaki, Takahiro Obara, Tomoko Takahashi, Hirokazu Kimura, Akihide Ryo, Naoto Yoshino, Yasushi Ono, Yasushi Muraki
Publikováno v:
Japanese journal of infectious diseases. 71(5)
Autor:
Shu-ichi Ikeda, Takahiko Tokuda, Nobuhiro Kotani, Shuhei Yamaguchi, Shotai Kobayashi, Shingo Yamagata, Takeshi Hattori, Akira Shirasawa
Publikováno v:
Amyloid. 9:31-34
A Japanese case with familial amyloidotic polyneuropathy (FAP) associated with the transthyretin mutation Thr60Ala (Appalachian-type mutation) is described This is the first reported case of a non-Caucasian harboring this type of TTR mutation. The pa
Autor:
Shotai Kobayashi, Shingo Mitaki, Genya Toyoda, Naoto Kouno, Hirokazu Bokura, Akira Shirasawa, Reiko Saika, Atuo Aoyama, Satoshi Abe, Shuhei Yamaguchi
Publikováno v:
Nosotchu. 33:182-184
脳卒中後にアパシーを合併することはよく知られている.またアパシーは血管性認知症に先行する症状であるとともに廃用性認知機能障害をきたす重要な要因でもあり,アパシーを早期
Autor:
Kazuya Yamashita, Kenichi Iijima, Yuji Watanabe, Akira Shirasawa, Satoru Kuroda, Hideaki Nishi
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 46:833-839
To determine the relationships among silent brain infarction (SBI), bone mineral density and milk consumption in elderly women, we studied 26 senile female outpatients with SBI in comparison with 18 age-matched controls.There was a significant differ
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 45:90-94
A型行動様式と血圧について1年間のfollow upをし, 性格の変化と血圧との関係を検討した。A型行動パターンスクリーニングテストのスコアの変化率と収縮期血圧, 拡張期血圧の変化率はとも
Autor:
Akira Shirasawa, Genya Toyoda, Satoshi Abe, Shuhei Yamaguchi, Hirokazu Bokura, Shingo Mitaki, Ryukichi Matsui
Publikováno v:
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. 47(1)
AIM To evaluate the efficacy, outcome, and side effects of tissue plasminogen activator for cerebral infarction in patients aged 75 years or older. METHODS Subjects consisted of 30 patients who had been treated with tissue plasminogen activator betwe